Estadístiques de PD-L1 Inhibitors as monotherapy for the first-line treatment of non-small-cell lung cancer in PD-L1 positive patients: a safety data network meta-analysis
Visites totals
| views | |
|---|---|
| PD-L1 Inhibitors as monotherapy for the first-line treatment of non-small-cell lung cancer in PD-L1 positive patients: a safety data network meta-analysis | 65 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 1 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| garcia-jcm-pdl1.pdf(legacy) | 27 |
| garcia-jcm-pdl1.pdf | 24 |
Vistes principals per país
| views | |
|---|---|
| United States | 58 |
| Spain | 3 |
| Colombia | 1 |
| India | 1 |
| Malaysia | 1 |
| Norway | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 22 |
| Mountain View | 7 |
| Menlo Park | 6 |
| Ashburn | 3 |
| Boardman | 2 |
| Tustin | 2 |
| Andover | 1 |
| Ann Arbor | 1 |
| Bilbao | 1 |
| Cambridge | 1 |
| Córdoba | 1 |
| Oslo | 1 |
| Sacramento | 1 |
| San Diego | 1 |
| Seattle | 1 |
| Shah Alam | 1 |
| Torremolinos | 1 |